Relationship between a state Medicaid formulary committee and a university-based drug information centerdoi:10.1093/ajhp/47.3.600Chyka Peter AWojciechowski Norbert JCampbell Jeffery WAmerican Journal of Hospital Pharmacy
while private systems are sustained by out-of-pocket expenses and voluntary health care payments (such as elective health insurance, financing from non-profit institutions and enterprise financing) (Immergut and Schneider2020).
INTRODUCTION: A large, statewide, fee-for-service Medicaid plan recently (October 2015) executed a complete switch from sublingual buprenorphine-naloxone [(SLBN), Suboxone ] to buccal buprenorphine-naloxone [(BBN), Bunavail ] on its preferred drug formulary. This complete formulary switch provided ...